• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局灶节段性肾小球硬化症和微小病变病的发病机制:肾小球蛋白质组学的见解

Pathogenesis of Focal Segmental Glomerulosclerosis and Minimal Change Disease: Insights from Glomerular Proteomics.

作者信息

Maslyennikov Yuriy, Pralea Ioana-Ecaterina, Bărar Andrada Alina, Rusu Crina Claudia, Moldovan Diana Tania, Potra Alina Ramona, Tirinescu Dacian, Țicală Maria, Urs Alexandra, Zamfir Paula, Boțan Emil, Mureșan Ximena-Maria, Pîrv Simina, Nuțu Andreea, Berindan-Neagoe Ioana, Iuga Cristina-Adela, Kacso Ina Maria

机构信息

Department of Nephrology, Faculty of Medicine, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.

Personalized Medicine and Rare Diseases Department, MEDFUTURE-Institute for Biomedical Research, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.

出版信息

Life (Basel). 2025 Mar 23;15(4):527. doi: 10.3390/life15040527.

DOI:10.3390/life15040527
PMID:40283082
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12028441/
Abstract

Podocyte injury is a hallmark of both focal segmental glomerulosclerosis (FSGS) and minimal change disease (MCD), ultimately reflected in foot process effacement and proteinuria. Triggers and pathogenic pathways leading to podocyte cytoskeleton rearrangements are, however, incompletely explained. Here, we aimed to contribute to the understanding of these pathways using tissue bottom-up proteomic profiling of laser-capture microdissected glomeruli from MCD and FSGS. Forty-six differentially expressed proteins were identified between the two groups ( < 0.05, |FC| ≥ 1.2). Pathway analysis showed that 16 out of 46 proteins were associated with the immune system, with E2 ubiquitin-conjugating enzyme (UBE2K) and complement factor H-related protein-1 (CFHR1) yielding the highest fold change in FSGS compared to MCD. The two target proteins were further validated through immunohistochemistry, confirming the podocyte localization of UBE2K and endothelial staining of CFHR. Additionally, several other differentially expressed proteins were linked to the cytoskeleton structure and its regulation. Our results point to the possibility that complement dysregulation may be the source of cytoskeleton rearrangement in FSGS.

摘要

足细胞损伤是局灶节段性肾小球硬化(FSGS)和微小病变病(MCD)的共同特征,最终表现为足突消失和蛋白尿。然而,导致足细胞细胞骨架重排的触发因素和致病途径尚未完全阐明。在此,我们旨在通过对MCD和FSGS患者激光捕获显微切割肾小球进行组织自下而上的蛋白质组分析,来增进对这些途径的理解。两组之间共鉴定出46种差异表达蛋白(<0.05,|FC|≥1.2)。通路分析表明,46种蛋白中有16种与免疫系统相关,其中E2泛素结合酶(UBE2K)和补体因子H相关蛋白1(CFHR1)在FSGS中与MCD相比具有最高的倍数变化。通过免疫组织化学进一步验证了这两种靶蛋白,证实了UBE2K在足细胞中的定位以及CFHR在内皮细胞中的染色。此外,其他几种差异表达蛋白与细胞骨架结构及其调节有关。我们的结果表明,补体失调可能是FSGS中细胞骨架重排的根源。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96b6/12028441/16f0cd86c1b2/life-15-00527-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96b6/12028441/4a48febddb06/life-15-00527-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96b6/12028441/c1bb8632de2b/life-15-00527-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96b6/12028441/e04b5f92c215/life-15-00527-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96b6/12028441/16f0cd86c1b2/life-15-00527-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96b6/12028441/4a48febddb06/life-15-00527-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96b6/12028441/c1bb8632de2b/life-15-00527-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96b6/12028441/e04b5f92c215/life-15-00527-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96b6/12028441/16f0cd86c1b2/life-15-00527-g004.jpg

相似文献

1
Pathogenesis of Focal Segmental Glomerulosclerosis and Minimal Change Disease: Insights from Glomerular Proteomics.局灶节段性肾小球硬化症和微小病变病的发病机制:肾小球蛋白质组学的见解
Life (Basel). 2025 Mar 23;15(4):527. doi: 10.3390/life15040527.
2
Potential Urine Proteomic Biomarkers for Focal Segmental Glomerulosclerosis and Minimal Change Disease.局灶节段性肾小球硬化症和微小病变性肾病的潜在尿液蛋白质组生物标志物。
Int J Mol Sci. 2022 Oct 20;23(20):12607. doi: 10.3390/ijms232012607.
3
Comparative differential proteomic analysis of minimal change disease and focal segmental glomerulosclerosis.微小病变病与局灶节段性肾小球硬化的比较性差异蛋白质组学分析
BMC Nephrol. 2017 Feb 3;18(1):49. doi: 10.1186/s12882-017-0452-6.
4
Ultrastructural features and expression of cytoskeleton proteins of podocyte from patients with minimal change disease and focal segmental glomerulosclerosis.微小病变病和局灶节段性肾小球硬化症患者足细胞的超微结构特征及细胞骨架蛋白表达
Ren Fail. 2008;30(5):477-83. doi: 10.1080/08860220802060497.
5
In situ evaluation of podocytes in patients with focal segmental glomerulosclerosis and minimal change disease.在局灶节段性肾小球硬化和微小病变性肾病患者中肾小球脏层上皮细胞的原位评估。
PLoS One. 2020 Nov 4;15(11):e0241745. doi: 10.1371/journal.pone.0241745. eCollection 2020.
6
A molecular profile of focal segmental glomerulosclerosis from formalin-fixed, paraffin-embedded tissue.从福尔马林固定、石蜡包埋组织中得到局灶节段性肾小球硬化的分子特征。
Am J Pathol. 2010 Oct;177(4):1674-86. doi: 10.2353/ajpath.2010.090746. Epub 2010 Sep 16.
7
A Prospective Study on Complement Activation Distinguishes Focal Segmental Glomerulosclerosis from Minimal Change Disease.一项关于补体激活的前瞻性研究区分局灶节段性肾小球硬化与微小病变肾病。
Kidney Int Rep. 2023 Dec 29;9(3):661-670. doi: 10.1016/j.ekir.2023.12.015. eCollection 2024 Mar.
8
Synaptopodin immunoexpression in steroid-responsive and steroid-resistant minimal change disease and focal segmental glomerulosclerosis.突触足蛋白在类固醇反应性和类固醇抵抗性微小病变病及局灶节段性肾小球硬化症中的免疫表达
Nefrologia. 2007;27(6):710-5.
9
Podocyte and endothelial injury in focal segmental glomerulosclerosis: an ultrastructural analysis.局灶节段性肾小球硬化中的足细胞和内皮细胞损伤:超微结构分析
Virchows Arch. 2015 Oct;467(4):449-58. doi: 10.1007/s00428-015-1821-9. Epub 2015 Aug 13.
10
Podocin and beta dystroglycan expression to study podocyte-podocyte and basement membrane matrix connections in adult protienuric states.研究成年蛋白尿状态下足细胞-足细胞和基底膜基质连接,检测 podocin 和β-肌营养不良蛋白的表达。
Diagn Pathol. 2014 Feb 21;9:40. doi: 10.1186/1746-1596-9-40.

本文引用的文献

1
Role of Podocyte in Kidney Disease.足细胞在肾脏病中的作用。
Front Biosci (Landmark Ed). 2024 Jul 11;29(7):250. doi: 10.31083/j.fbl2907250.
2
The Lectin Pathway-A Dominant Pattern of the Complement System Activation in Primary Focal Segmental Glomerulosclerosis?凝集素途径——原发性局灶节段性肾小球硬化中补体系统激活的主要模式?
Kidney Int Rep. 2024 Apr 1;9(6):1925-1926. doi: 10.1016/j.ekir.2024.02.1441. eCollection 2024 Jun.
3
Minimal Change Disease: Pathogenetic Insights from Glomerular Proteomics.微小病变性肾病:肾小球蛋白质组学的发病机制研究进展。
Int J Mol Sci. 2024 May 21;25(11):5613. doi: 10.3390/ijms25115613.
4
A Prospective Study on Complement Activation Distinguishes Focal Segmental Glomerulosclerosis from Minimal Change Disease.一项关于补体激活的前瞻性研究区分局灶节段性肾小球硬化与微小病变肾病。
Kidney Int Rep. 2023 Dec 29;9(3):661-670. doi: 10.1016/j.ekir.2023.12.015. eCollection 2024 Mar.
5
Role of biophysics and mechanobiology in podocyte physiology.生物物理学和机械生物学在足细胞生理学中的作用。
Nat Rev Nephrol. 2024 Jun;20(6):371-385. doi: 10.1038/s41581-024-00815-3. Epub 2024 Mar 5.
6
Complement Activation in Nephrotic Glomerular Diseases.肾病性肾小球疾病中的补体激活
Biomedicines. 2024 Feb 18;12(2):455. doi: 10.3390/biomedicines12020455.
7
Cytoskeleton Rearrangement in Podocytopathies: An Update.足细胞病中细胞骨架重排:最新研究进展。
Int J Mol Sci. 2024 Jan 4;25(1):647. doi: 10.3390/ijms25010647.
8
"Idiopathic" minimal change nephrotic syndrome: a podocyte mystery nears the end.特发性微小病变肾病综合征:足细胞之谜即将揭晓。
Am J Physiol Renal Physiol. 2023 Dec 1;325(6):F685-F694. doi: 10.1152/ajprenal.00219.2023. Epub 2023 Oct 5.
9
A guide to complement biology, pathology and therapeutic opportunity.补体生物学、病理学与治疗机会指南
Nat Rev Immunol. 2024 Feb;24(2):118-141. doi: 10.1038/s41577-023-00926-1. Epub 2023 Sep 5.
10
Mapping antigens of membranous nephropathy: almost there.膜性肾病抗原的定位:已近成功。
Kidney Int. 2023 Mar;103(3):469-472. doi: 10.1016/j.kint.2023.01.003.